A systematic review of the safety and efficacy of convalescent plasma or immunoglobulin treatment for people with severe respiratory viral infections due to coronaviruses or influe... by Kimber, C, Lamikanra, AA, Geneen, LJ, Sandercock, J, Dorée, C, Valk, SJ, Estcourt, LJ

Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS‐CoV‐2 by Valk, SJ, Piechotta, V, Kimber, C, Chai, KL, Monsef, I, Doree, C, Wood, EM, Lamikanra, AA, Roberts, DJ, McQuilten, Z, So-Osman, C, Estcourt, LJ, Skoetz, N

Hyperimmune immunoglobulin for people with COVID-19 by Kimber, C, Valk, SJ, Chai, KL, Piechotta, V, Iannizzi, C, Monsef, I, Wood, EM, Lamikanra, AA, Roberts, DJ, McQuilten, Z, So-Osman, C, Estcourt, LJ, Skoetz, N

Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review by Piechotta, V, Iannizzi, C, Chai, KL, Valk, SJ, Kimber, C, Dorando, E, Monsef, I, Wood, EM, Lamikanra, AA, Roberts, DJ, McQuilten, Z, So-Osman, C, Estcourt, LJ, Skoetz, N

SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19 by Hirsch, C, Valk, SJ, Piechotta, V, Chai, KL, Estcourt, LJ, Monsef, I, Salomon, S, Tomlinson, E, Popp, M, Wood, EM, So-Osman, C, Roberts, DJ, McQuilten, Z, Skoetz, N, Kreuzberger, N

SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19 by Kreuzberger, N, Hirsch, C, Chai, KL, Tomlinson, E, Khosravi, Z, Popp, M, Neidhardt, M, Piechotta, V, Salomon, S, Valk, SJ, Monsef, I, Schmaderer, C, Wood, EM, So-Osman, C, Roberts, DJ, McQuilten, Z, Estcourt, LJ, Skoetz, N